Clinical Trial Update: A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for CYB003 (a psilocybin analog) in healthy participants with and without major depressive disorder, covering Phase 1 and Phase 2 comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• CYB003 (deuterated psilocin analog)

Snippet

Sponsor: Cybin IRL Limited | Conditions: Major Depressive Disorder | Phase 1, Phase 2 | Status: COMPLETED